Tudor Investment Corporation »

Structure Therapeutics shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Structure Therapeutics (GPCR) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Structure Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Structure Therapeutics held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Structure Therapeutics by Tudor Investment Corporation

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.6M 75k 48.20
2025-12-31 $2.4M 35k 69.55

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)
Invesco Qqq Trust Series 1 - US ETP ETF Option Call Option (QQQ)
State Street SPDR S&P 500 ETF Trust - US ETP ETF Option Call Option (SPY)
Spdr Gold Shares - US ETP ETF Option Call Option (GLD)
Nvidia Corp - US Equity (NVDA)
State Street Energy Select Sector SPDR ETF - US ET ETF Option Call Option (XLE)
Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)
Microsoft Corp - US Equity (MSFT)
State Street Financial Select Sector SPDR ETF - US ETF Option Call Option (XLF)
Tesla Inc - US Equity (TSLA)
Ishares China Large-Cap Etf - US ETP ETF Option Call Option (FXI)
Meta Platforms Inc - US Equity (META)
Taiwan Semiconductor Manufacturing Co Ltd - US Depository Receipt (TSM)
Alibaba Group Holding Ltd - US Depository Receipt (BABA)
Amazon.Com Inc - US Equity (AMZN)

View all positions for Tudor Investment Corporation

Top funds holding Structure Therapeutics

FMR
Wellington Management Company
venBio Select Advisor
Henderson Group
Deep Track Capital
BVF
Morgan Stanley
Principal Financial Group
Driehaus Capital Management
OrbiMed Advisors
American Century Companies
Baker Bros. Advisors
Siren
Casdin Capital
Capitolis Liquid Global Markets

View all funds holding Structure Therapeutics